Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003133719 | SCV003815667 | uncertain significance | Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures | 2022-06-28 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003396906 | SCV004103042 | uncertain significance | IRF2BPL-related disorder | 2023-09-17 | criteria provided, single submitter | clinical testing | The IRF2BPL c.2200C>T variant is predicted to result in the amino acid substitution p.Pro734Ser. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |